Beril Tom

Bradykinin Potentiation by Angiotensin-(1-7) and ACE Inhibitors Correlates With ACE C- and N-Domain Blockade

Beril Tom, René de Vries, Pramod R. Saxena et al. · Hypertension · 2001 · 104 citations · Full text

Hypertension, Bradykinin Potentiation, Cardiovascular Pharmacology +17

Bradykinin potentiation by ACE inhibitors: a matter of metabolism

Beril Tom, Andreas Dendorfer, René de Vries et al. · British Journal of Pharmacology · 2002 · 65 citations · Full text

Bradykinin Potentiation, Cardiovascular Pharmacology, Pharmacotherapy +18

Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I–Induced Vasoconstriction

Joep H.M. van Esch, Beril Tom, Vincent Dive et al. · Hypertension · 2004 · 63 citations · Full text

Hypertension, Angiotensin I–induced Vasoconstriction, Cardiovascular Pharmacology +16

ACE- Versus Chymase-Dependent Angiotensin II Generation in Human Coronary Arteries

Beril Tom, Ingrid M. Garrelds, Elizabeth Scalbert et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 58 citations · Full text

<scp>L</scp>‐NAME‐resistant bradykinin‐induced relaxation in porcine coronary arteries is NO‐dependent: effect of ACE inhibition

A. H. Jan Danser, Beril Tom, René de Vries et al. · British Journal of Pharmacology · 2000 · 57 citations · Full text

Molecular Pharmacology, Porcine Coronary Arteries, Ace Inhibition +15